Clinical trials for Chikungunya
15 recruiting or active trials synced from ClinicalTrials.gov.
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data- RECRUITINGPHASE2, PHASE3NCT07555392A Seamless Phase II/III, Observer-blind, to Evaluate Immunogenicity and Safety of Chikungunya Virus Vaccine in Healthy Subjects 12-65Years of Age.Bharat Biotech International Limited
- ENROLLING BY INVITATIONNCT07347002Observational Study to Assess the Effectiveness of VLA1553 Vaccine in Preventing Chikungunya During a Pilot Vaccination Strategy in BrazilValneva Austria GmbH
- ENROLLING BY INVITATIONNCT07254702Prospective Safety Cohort Study After VLA1553 Vaccination in Municipalities Selected for Participation in the VLA1553 Pilot Vaccination Strategy in BrazilValneva Austria GmbH
- ACTIVE NOT RECRUITINGNCT07163845Assessment of Chikungunya Virus Seroprevalence Before VLA1553 Vaccination in the Municipalities Selected for Participation in the VLA1553 Pilot Vaccination Strategy in BrazilValneva Austria GmbH
- ENROLLING BY INVITATIONNCT07520279Xpert® Tropical Fever Test on GeneXpert® Edge X SystemCepheid
- ACTIVE NOT RECRUITINGNCT06651372The Interest of Systematic Screening for Dengue, Chikungunya, and Zika, in Malaria-negative Return TravelersUniversity Hospital, Strasbourg, France
- RECRUITINGNCT07120724Real-World Study on Chinese Medicine for Treating Chikungunya FeverGuangzhou University of Traditional Chinese Medicine
- RECRUITINGPhase 3NCT07003984A Safety and Immunogenicity Study of CHIKV VLP Vaccine in Children.Bavarian Nordic · PI: Patrick Ajiboye, MD
- RECRUITINGPhase 4NCT06928753Real-world Effectiveness, Safety and Immunogenicity of Chikungunya Vaccination in Populations at Risk of Severe or Complicated Forms: Prospective Study in La RéunionCentre Hospitalier Universitaire de la Réunion · PI: Patrick GERARDIN, MD
- ACTIVE NOT RECRUITINGN/ANCT07523126EFFECT OF TRANSCUTANEOUS ELECTRONEURO-STIMULATION OF THE VAGUS NERVE ON JOINT PAIN SEQUELAE OF CHIKUNGUNYA FEVER IN THE LOWER LIMBSUniversidade Federal de Pernambuco
- ACTIVE NOT RECRUITINGPhase 3NCT06007183Long-term Follow-up Study to Evaluate Safety and Immunogenicity of PXVX0317 Single or Booster VaccinationBavarian Nordic · PI: Patrick Ajiboye, MD
- ACTIVE NOT RECRUITINGPhase 3NCT04483466Methotrexate Treatment of Arthritis Caused by Chikungunya Virus (MARCH)George Washington University
- ACTIVE NOT RECRUITINGPhase 3NCT04838444Antibody Persistence And Long Term Safety Of A Chikungunya Virus Vaccine (VLA1553)Valneva Austria GmbH · PI: Valneva Clinical Development
- RECRUITINGN/ANCT04619823Virological and Immunological Determinants of Arbovirus Infection in New CaledoniaInstitut Pasteur · PI: Myrielle Dupont-Rouzeyrol, PhD
- RECRUITINGNCT04615364Genetic Evolution of Arboviruses in New Caledonia Between 1995 and 2024 and Impact of WolbachiaInstitut Pasteur · PI: Myrielle Dupont-Rouzeyrol, PhD